Results 161 to 170 of about 3,006,553 (325)
Mutational retracts and extensions of mutations [PDF]
openaire +2 more sources
TRPM8 levels determine tumor vulnerability to channel agonists
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo+18 more
wiley +1 more source
The Consequences of Mutation during the Growth of Biochemical Mutants of Escherichia coli [PDF]
Francis J. Ryan, Lillian K. Schneider
openalex +1 more source
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte+10 more
wiley +1 more source
The mutation theory; experiments and observations on the origin of species in the vegetable kingdom
Hugo de Vries+2 more
openalex +2 more sources
THE RELATIVE FREQUENCY OF MUTATIONS IN DIFFERENT CHROMOSOMES OF DROSOPHILA MELANOGASTER I. LETHAL MUTATIONS [PDF]
Raissa L. Berg
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Editorial: Legume breeding in transition: innovation and outlook
Aamir Raina+6 more
doaj +1 more source